ReCode Therapeutics

United States
Wright City, Oklahoma, United States, 75219

Company profile

ReCode Therapeutics company profile

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics. Its selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. The company aims to leverage innovative technologies to provide solutions for individuals affected by genetic diseases.

Business identity

Contact email
[email protected]
Phone number
469-306-1618
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2015-01-01, Year

Headquarters

Postal code
75219
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
8
Total equity funding
$357M
Last funding
Debt Financing / $29.4M / 2025-09-29
Last equity funding
Series Unknown / $15M
Investors
17
Lead investors
8
Founders
3
Articles
81

Founders and investors

Founders

Daniel SiegwartMichael TorresPhilip Thomas

Lead investors

Bioluminescence VenturesColt VenturesCystic Fibrosis FoundationEcoR1 CapitalLeaps by BayerMatrix Capital ManagementOrbiMedPfizer Venture Investments

Investors

EcoR1 CapitalOrbiMedOUP (Osage University Partners)Sanofi VenturesVida Ventures